Click here to get full coverage on Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"  Yahoo Finance

Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Click here to get full coverage on (CAH) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

(CAH) Risk Channels and Responsive Allocation  news.stocktradersdaily.com

(CAH) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Click here to get full coverage on After decades with only one option, new therapies emerge for congenital adrenal hyperplasia - Healio

After decades with only one option, new therapies emerge for congenital adrenal hyperplasia  Healio

After decades with only one option, new therapies emerge for congenital adrenal hyperplasia - Healio

Click here to get full coverage on The corpus callosum in people with congenital adrenal hyperplasia (CAH) | Scientific Reports - Nature

The corpus callosum in people with congenital adrenal hyperplasia (CAH) | Scientific Reports  Nature

The corpus callosum in people with congenital adrenal hyperplasia (CAH) | Scientific Reports - Nature

Click here to get full coverage on New horizons in treatments for classic congenital adrenal hyperplasia (CAH) - Mayo Clinic Press

New horizons in treatments for classic congenital adrenal hyperplasia (CAH)  Mayo Clinic Press

New horizons in treatments for classic congenital adrenal hyperplasia (CAH) - Mayo Clinic Press

Click here to get full coverage on How to Manage Mental Health and Congenital Adrenal Hyperplasia - Everyday Health

How to Manage Mental Health and Congenital Adrenal Hyperplasia  Everyday Health

How to Manage Mental Health and Congenital Adrenal Hyperplasia - Everyday Health

Click here to get full coverage on Neurocrine shares new one-year data from trial of Crenessity for CAH - Clinical Trials Arena

Neurocrine shares new one-year data from trial of Crenessity for CAH  Clinical Trials Arena

Neurocrine shares new one-year data from trial of Crenessity for CAH - Clinical Trials Arena

Click here to get full coverage on Stock Analysis | Cardinal Health Outlook - A Mixed Bag of Signals for CAH Investors - AInvest

Stock Analysis | Cardinal Health Outlook - A Mixed Bag of Signals for CAH Investors  AInvest

Stock Analysis | Cardinal Health Outlook - A Mixed Bag of Signals for CAH Investors - AInvest

Click here to get full coverage on 2 Reasons to Watch CAH and 1 to Stay Cautious - FinancialContent

2 Reasons to Watch CAH and 1 to Stay Cautious  FinancialContent

2 Reasons to Watch CAH and 1 to Stay Cautious - FinancialContent

Click here to get full coverage on New CAH Method II Billing Requirement Effective July 1, 2025 - Forvis Mazars US

New CAH Method II Billing Requirement Effective July 1, 2025  Forvis Mazars US

New CAH Method II Billing Requirement Effective July 1, 2025 - Forvis Mazars US

Click here to get full coverage on Crinecerfont Shows Lasting Efficacy in Treating Adult CAH, with Richard Auchus, MD, PhD - HCPLive

Crinecerfont Shows Lasting Efficacy in Treating Adult CAH, with Richard Auchus, MD, PhD  HCPLive

Crinecerfont Shows Lasting Efficacy in Treating Adult CAH, with Richard Auchus, MD, PhD - HCPLive

Click here to get full coverage on CAH awards 14 faculty and staff for excellence in teaching and service - Clemson News

CAH awards 14 faculty and staff for excellence in teaching and service  Clemson News

CAH awards 14 faculty and staff for excellence in teaching and service - Clemson News

Click here to get full coverage on What Hormones Are Affected by CAH? - Cleveland Clinic Health Essentials

What Hormones Are Affected by CAH?  Cleveland Clinic Health Essentials

What Hormones Are Affected by CAH? - Cleveland Clinic Health Essentials

Click here to get full coverage on Cardinal Health (CAH) Expands At-Home Solutions Network With New Distribution Centers - Yahoo Finance

Cardinal Health (CAH) Expands At-Home Solutions Network With New Distribution Centers  Yahoo Finance

Cardinal Health (CAH) Expands At-Home Solutions Network With New Distribution Centers - Yahoo Finance

Click here to get full coverage on Avoiding Lag: Real-Time Signals in (CAH) Movement - news.stocktradersdaily.com

Avoiding Lag: Real-Time Signals in (CAH) Movement  news.stocktradersdaily.com

Avoiding Lag: Real-Time Signals in (CAH) Movement - news.stocktradersdaily.com

Click here to get full coverage on Cardinal Health (CAH) Falls on Dismal Revenue Performance - Yahoo Finance

Cardinal Health (CAH) Falls on Dismal Revenue Performance  Yahoo Finance

Cardinal Health (CAH) Falls on Dismal Revenue Performance - Yahoo Finance

Click here to get full coverage on Technical Reactions to CAH Trends in Macro Strategies - news.stocktradersdaily.com

Technical Reactions to CAH Trends in Macro Strategies  news.stocktradersdaily.com

Technical Reactions to CAH Trends in Macro Strategies - news.stocktradersdaily.com

Click here to get full coverage on Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why  Yahoo Finance

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance

Click here to get full coverage on Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - Yahoo Finance

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term  Yahoo Finance

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Returns At Cardinal Health (NYSE:CAH) Are On The Way Up - Yahoo Finance

Returns At Cardinal Health (NYSE:CAH) Are On The Way Up  Yahoo Finance

Returns At Cardinal Health (NYSE:CAH) Are On The Way Up - Yahoo Finance

Click here to get full coverage on FDA Grants Atumelnant Orphan Drug Designation for Congenital Adrenal Hyperplasia - HCPLive

FDA Grants Atumelnant Orphan Drug Designation for Congenital Adrenal Hyperplasia  HCPLive

FDA Grants Atumelnant Orphan Drug Designation for Congenital Adrenal Hyperplasia - HCPLive

Click here to get full coverage on UCPS to add full nursing coverage for kids with life-threatening disorder - WCNC

UCPS to add full nursing coverage for kids with life-threatening disorder  WCNC

UCPS to add full nursing coverage for kids with life-threatening disorder - WCNC

Click here to get full coverage on CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls - Yahoo Finance

CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls  Yahoo Finance

CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls - Yahoo Finance

Click here to get full coverage on Cardinal Health's (NYSE:CAH) investors will be pleased with their stellar 242% return over the last five years - Yahoo Finance

Cardinal Health's (NYSE:CAH) investors will be pleased with their stellar 242% return over the last five years  Yahoo Finance

Cardinal Health's (NYSE:CAH) investors will be pleased with their stellar 242% return over the last five years - Yahoo Finance

Click here to get full coverage on Three CAH students honored for their impact on the Clemson community - Clemson News

Three CAH students honored for their impact on the Clemson community  Clemson News

Three CAH students honored for their impact on the Clemson community - Clemson News

Click here to get full coverage on Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia - Frontiers

Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia  Frontiers

Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia - Frontiers

Click here to get full coverage on What to Do During a Classic CAH Adrenal Crisis - MedPage Today

What to Do During a Classic CAH Adrenal Crisis  MedPage Today

What to Do During a Classic CAH Adrenal Crisis - MedPage Today

Click here to get full coverage on 340,000 Sq Ft Medical Supply Hub: Cardinal Health Launches Texas Center, Plans California Expansion - Stock Titan

340,000 Sq Ft Medical Supply Hub: Cardinal Health Launches Texas Center, Plans California Expansion  Stock Titan

340,000 Sq Ft Medical Supply Hub: Cardinal Health Launches Texas Center, Plans California Expansion - Stock Titan

Click here to get full coverage on Should Value Investors Buy Cardinal Health (CAH) Stock? - sharewise.com

Should Value Investors Buy Cardinal Health (CAH) Stock?  sharewise.com

Should Value Investors Buy Cardinal Health (CAH) Stock? - sharewise.com

Click here to get full coverage on Responsive Playbooks and the CAH Inflection - news.stocktradersdaily.com

Responsive Playbooks and the CAH Inflection  news.stocktradersdaily.com

Responsive Playbooks and the CAH Inflection - news.stocktradersdaily.com

Click here to get full coverage on Richard Auchus, MD, on how crinecerfont is changing CAH treatment - Contemporary Pediatrics

Richard Auchus, MD, on how crinecerfont is changing CAH treatment  Contemporary Pediatrics

Richard Auchus, MD, on how crinecerfont is changing CAH treatment - Contemporary Pediatrics

Click here to get full coverage on Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia - The Lancet

Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia  The Lancet

Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia - The Lancet

Click here to get full coverage on All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy - Yahoo Finance

All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy  Yahoo Finance

All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy - Yahoo Finance

Click here to get full coverage on Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know  Yahoo Finance

Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Click here to get full coverage on Crenessity benefits continue for adults, children with congenital adrenal hyperplasia - Healio

Crenessity benefits continue for adults, children with congenital adrenal hyperplasia  Healio

Crenessity benefits continue for adults, children with congenital adrenal hyperplasia - Healio

Click here to get full coverage on Cardinal Health, Inc. (CAH)’s CEO Is So Good, The Recent Earnings Surprised Me, Says Jim Cramer - Yahoo Finance

Cardinal Health, Inc. (CAH)’s CEO Is So Good, The Recent Earnings Surprised Me, Says Jim Cramer  Yahoo Finance

Cardinal Health, Inc. (CAH)’s CEO Is So Good, The Recent Earnings Surprised Me, Says Jim Cramer - Yahoo Finance

Click here to get full coverage on CAHtalyst Trial Shows Crenessity Sustains Efficacy in Classic Congenital Adrenal Hyperplasia - Applied Clinical Trials

CAHtalyst Trial Shows Crenessity Sustains Efficacy in Classic Congenital Adrenal Hyperplasia  Applied Clinical Trials

CAHtalyst Trial Shows Crenessity Sustains Efficacy in Classic Congenital Adrenal Hyperplasia - Applied Clinical Trials

Click here to get full coverage on Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors  Yahoo Finance

Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Click here to get full coverage on New Data Back Crinecerfont in Congenital Adrenal Hyperplasia - Medscape

New Data Back Crinecerfont in Congenital Adrenal Hyperplasia  Medscape

New Data Back Crinecerfont in Congenital Adrenal Hyperplasia - Medscape

Click here to get full coverage on Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia - PR Newswire

Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia  PR Newswire

Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia - PR Newswire

Click here to get full coverage on Cardinal Health (NYSE:CAH) Misses Q1 Revenue Estimates - Yahoo Finance

Cardinal Health (NYSE:CAH) Misses Q1 Revenue Estimates  Yahoo Finance

Cardinal Health (NYSE:CAH) Misses Q1 Revenue Estimates - Yahoo Finance

Click here to get full coverage on Cardinal Health (CAH) Tops Q4 Earnings Estimates - Yahoo Finance

Cardinal Health (CAH) Tops Q4 Earnings Estimates  Yahoo Finance

Cardinal Health (CAH) Tops Q4 Earnings Estimates - Yahoo Finance

Click here to get full coverage on Adults, Kids With Classic CAH May Have Better Metabolic Profiles With Crinecerfont - MedPage Today

Adults, Kids With Classic CAH May Have Better Metabolic Profiles With Crinecerfont  MedPage Today

Adults, Kids With Classic CAH May Have Better Metabolic Profiles With Crinecerfont - MedPage Today

Click here to get full coverage on Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint - HCPLive

Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint  HCPLive

Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint - HCPLive

Click here to get full coverage on Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH) - Yahoo Finance

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)  Yahoo Finance

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH) - Yahoo Finance

Click here to get full coverage on Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers - Frontiers

Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers  Frontiers

Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers - Frontiers

Click here to get full coverage on Crinecerfont Reduces Steroid Use for Pediatric CAH in Phase 3 Analysis - HCPLive

Crinecerfont Reduces Steroid Use for Pediatric CAH in Phase 3 Analysis  HCPLive

Crinecerfont Reduces Steroid Use for Pediatric CAH in Phase 3 Analysis - HCPLive

Click here to get full coverage on Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications - Endocrine Society

Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications  Endocrine Society

Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications - Endocrine Society

Click here to get full coverage on Cardinal Health (CAH) Reports Earnings Tomorrow: What To Expect - Yahoo Finance

Cardinal Health (CAH) Reports Earnings Tomorrow: What To Expect  Yahoo Finance

Cardinal Health (CAH) Reports Earnings Tomorrow: What To Expect - Yahoo Finance

Click here to get full coverage on Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings? - Yahoo Finance

Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?  Yahoo Finance

Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings? - Yahoo Finance

Click here to get full coverage on Stock Analysis | Cardinal Health Outlook - Mixed Signals Amid Strong Fundamentals and Analyst Optimism - AInvest

Stock Analysis | Cardinal Health Outlook - Mixed Signals Amid Strong Fundamentals and Analyst Optimism  AInvest

Stock Analysis | Cardinal Health Outlook - Mixed Signals Amid Strong Fundamentals and Analyst Optimism - AInvest

Click here to get full coverage on Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia - Endocrine Society

Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia  Endocrine Society

Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia - Endocrine Society

Click here to get full coverage on FDA Approves Drug for Rare Adrenal Gland Disorder - WebMD

FDA Approves Drug for Rare Adrenal Gland Disorder  WebMD

FDA Approves Drug for Rare Adrenal Gland Disorder - WebMD

Click here to get full coverage on Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook - Yahoo Finance

Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook  Yahoo Finance

Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook - Yahoo Finance

Click here to get full coverage on Cardinal Health Nears $260M Volume Pit Stop at 414th Rank Amid Modest 0.52% Rally and Bullish Bias - AInvest

Cardinal Health Nears $260M Volume Pit Stop at 414th Rank Amid Modest 0.52% Rally and Bullish Bias  AInvest

Cardinal Health Nears $260M Volume Pit Stop at 414th Rank Amid Modest 0.52% Rally and Bullish Bias - AInvest

Click here to get full coverage on Stock Analysis | Cardinal Health Outlook - Mixed Signals as Analysts Stay Bullish - AInvest

Stock Analysis | Cardinal Health Outlook - Mixed Signals as Analysts Stay Bullish  AInvest

Stock Analysis | Cardinal Health Outlook - Mixed Signals as Analysts Stay Bullish - AInvest

Click here to get full coverage on Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Click here to get full coverage on Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance

Cardinal Health (CAH) Laps the Stock Market: Here's Why  Yahoo Finance

Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance

Click here to get full coverage on Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAH - Contemporary Pediatrics

Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAH  Contemporary Pediatrics

Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAH - Contemporary Pediatrics

Click here to get full coverage on Male Bone Health at Risk in Congenital Adrenal Hyperplasia - Medscape

Male Bone Health at Risk in Congenital Adrenal Hyperplasia  Medscape

Male Bone Health at Risk in Congenital Adrenal Hyperplasia - Medscape

Click here to get full coverage on More Benefits Reported With Crinecerfont in Adults, Kids With CAH - MedPage Today

More Benefits Reported With Crinecerfont in Adults, Kids With CAH  MedPage Today

More Benefits Reported With Crinecerfont in Adults, Kids With CAH - MedPage Today

Click here to get full coverage on ‘Game Changer’ Approved for Congenital Adrenal Hyperplasia - Medscape

‘Game Changer’ Approved for Congenital Adrenal Hyperplasia  Medscape

‘Game Changer’ Approved for Congenital Adrenal Hyperplasia - Medscape

Click here to get full coverage on Cardinal Health, Inc. (CAH) CEO Is “Terrific,” Says Jim Cramer - Yahoo Finance

Cardinal Health, Inc. (CAH) CEO Is “Terrific,” Says Jim Cramer  Yahoo Finance

Cardinal Health, Inc. (CAH) CEO Is “Terrific,” Says Jim Cramer - Yahoo Finance

Click here to get full coverage on Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance

Are Investors Undervaluing Cardinal Health (CAH) Right Now?  Yahoo Finance

Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance

Click here to get full coverage on Crinecerfont Maintains A4, GC Reductions in Pediatric CAH at 1 Year - Endocrinology Advisor

Crinecerfont Maintains A4, GC Reductions in Pediatric CAH at 1 Year  Endocrinology Advisor

Crinecerfont Maintains A4, GC Reductions in Pediatric CAH at 1 Year - Endocrinology Advisor

Click here to get full coverage on Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?  Yahoo Finance

Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance

Click here to get full coverage on Classic Congenital Adrenal Hyperplasia: Understanding Treatment Options - MedPage Today

Classic Congenital Adrenal Hyperplasia: Understanding Treatment Options  MedPage Today

Cardinal Health Inc (CAH)

Price Chart

Key Statistics

Technicals

About CAH

Latest News

Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

(CAH) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

After decades with only one option, new therapies emerge for congenital adrenal hyperplasia - Healio

Environment, Social and Governance (ESG) Risk Ratings

Controversy Level

Advanced Charts

Top Gainers

Top Losers